Cspc Baike (shandong) Biopharmaceutical Co., Ltd.

This study is testing an investigational injection called CM326 to see if it can reduce severe asthma flare-ups and improve lung function and quality of life in adults with moderate to severe asthma. About 230 participants will receive either CM326 or a placebo injection for 52 w…

This study is testing an investigational drug called CM326 to see if it can safely reduce nasal polyps and ease congestion in adults with chronic sinusitis. About 212 participants will receive either the drug or a placebo for 24 weeks, followed by a longer open-label period. The …